BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 21704664)

  • 1. Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system.
    Lee SW; Yun MH; Jeong SW; In CH; Kim JY; Seo MH; Pai CM; Kim SO
    J Control Release; 2011 Oct; 155(2):262-71. PubMed ID: 21704664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine-stabilized mPEG-PDLLA (50/50) polymeric micelles of docetaxel by electrostatic mechanism for tumor-targeted delivery.
    Shi J; Zhang J; Shen Y; Tang L; Zhao J; Tu J; Tian Y; Feng Y
    Drug Deliv; 2015 Feb; 22(2):168-81. PubMed ID: 24215124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles.
    Tong SW; Xiang B; Dong DW; Qi XR
    Int J Pharm; 2012 Sep; 434(1-2):413-9. PubMed ID: 22698861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable and efficient delivery of docetaxel by micelle-encapsulation using a tripodal cyclotriphosphazene amphiphile.
    Jun YJ; Jadhav VB; Min JH; Cui JX; Chae SW; Choi JM; Kim IS; Choi SJ; Lee HJ; Sohn YS
    Int J Pharm; 2012 Jan; 422(1-2):374-80. PubMed ID: 22079718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-interactive mPEG-
    Gong F; Wang R; Zhu Z; Duan J; Teng X; Cui ZK
    Drug Deliv; 2020 Dec; 27(1):238-247. PubMed ID: 32003299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of mixed MPEG-PLA/Pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxel.
    Mu CF; Balakrishnan P; Cui FD; Yin YM; Lee YB; Choi HG; Yong CS; Chung SJ; Shim CK; Kim DD
    Biomaterials; 2010 Mar; 31(8):2371-9. PubMed ID: 20031202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of teniposide-loaded polymeric micelles for breast cancer therapy.
    Chu B; Shi S; Li X; Hu L; Shi L; Zhang H; Xu Q; Ye L; Lin G; Zhang N; Zhang X
    Int J Pharm; 2016 Nov; 513(1-2):118-129. PubMed ID: 27596115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
    Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B
    Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel monomethoxy polyethylene glycol-polylactic acid polymeric micelles with higher loading capacity for docetaxel and well-reconstitution characteristics and its anti-metastasis study.
    Li Y; Yang F; Chen W; Liu J; Huang W; Jin M; Gao Z
    Chem Pharm Bull (Tokyo); 2012; 60(9):1146-54. PubMed ID: 22976323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted nanoassembly loaded with docetaxel improves intracellular drug delivery and efficacy in murine breast cancer model.
    Gao Y; Chen L; Gu W; Xi Y; Lin L; Li Y
    Mol Pharm; 2008; 5(6):1044-54. PubMed ID: 19434922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles.
    Esmaeili F; Dinarvand R; Ghahremani MH; Ostad SN; Esmaily H; Atyabi F
    Anticancer Drugs; 2010 Jan; 21(1):43-52. PubMed ID: 19809300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of stabilized double loaded mPEG-PDLLA micelles for simultaneous delivery of paclitaxel and docetaxel.
    Ouahab A; Shao C; Shen Y; Tu J
    Drug Dev Ind Pharm; 2014 Jul; 40(7):860-8. PubMed ID: 23600653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.
    Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z
    Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
    Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
    Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and evaluation of mPEG-PLA micelles functionalized with drug-interactive domains as improved drug carriers for docetaxel delivery.
    Qi D; Gong F; Teng X; Ma M; Wen H; Yuan W; Cheng Y; Lu C
    J Biomater Sci Polym Ed; 2017 Oct; 28(14):1538-1555. PubMed ID: 28532250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is an alternative drug delivery system needed for docetaxel? The role of controlling epimerization in formulations and beyond.
    Manjappa AS; Goel PN; Vekataraju MP; Rajesh KS; Makwana K; Ukawala M; Nikam Y; Gude RP; Murthy RS
    Pharm Res; 2013 Oct; 30(10):2675-93. PubMed ID: 23756759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyglutamic acid-PEG nanocapsules as long circulating carriers for the delivery of docetaxel.
    Lollo G; Rivera-Rodriguez GR; Bejaud J; Montier T; Passirani C; Benoit JP; García-Fuentes M; Alonso MJ; Torres D
    Eur J Pharm Biopharm; 2014 May; 87(1):47-54. PubMed ID: 24530693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel.
    Yang Y; Wang J; Zhang X; Lu W; Zhang Q
    J Control Release; 2009 Apr; 135(2):175-82. PubMed ID: 19331864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
    Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L
    Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.